Another recent screening identified that H3K9 demethylation-mediated upregulation of BCAT1 and subsequent BCAA metabolic reprogramming is able to enhance the capacity for sublethal epidermal growth factor receptor (EGFR) inhibitor (TKI) resistance by producing ROS scavengers in lung cancer, which is a cancer where EGFR mutations are commonly found (Wang et al., 2019b)
But due to the various unknowns for what goes into a compounded medication and the variety of production processes, I recommend that people stay with brand-name medication, says Siegel
Klysz D, Tai X, Robert PA, Craveiro M, Cretenet G, Oburoglu L, et al
In this article: We don't have total control over what ads are being shown on this page
Our body is a very complex system
[Abstract]2025 Feb;12(7):e2407134